Skip to main content

Advertisement

Table 3 Actuarial and estimated cancer-related outcome in the study and control group

From: Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis

  All patients % (n = 212) Study group with neoadjuvant treatment % (n = 106) Control group without neoadjuvant treatment % (n = 106) p-value
Follow-Up in years (mean) 4.04 4.3 ± 2.55 3.8 ± 3.05 0.172
Actuarial outcome     
Cancer related survival     
 All UICC stages 69.8 67.9 71.7 0.65
 UICC stage 0-III 86.4 82.7 90.1 0.25
Disease free survival     
 UICC stage 0-III 76.5 70.4 82.7 0.09
Local recurrence     
 All UICC stages 5.2 5.7 4.7 1.00
 UICC stage 0-III 6.8 7.4 6.2 1.00
Estimated 5-year outcome     
Cancer related survival     
 All UICC stages 67.3 66.7 67.9 0.88
 UICC stage 0-III 85.8 82.0 89.6 0.32
Disease free survival     
 UICC stage 0-III 73.3 66.7 79.9 0.22
Local recurrence     
 All UICC stages 8.4 9.0 7.8 0.98
 UICC stage 0-III 8.5 9.2 7.9 0.95